lovastatin and Stroke
lovastatin has been researched along with Stroke in 15 studies
Research
Studies (15)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (6.67) | 18.2507 |
| 2000's | 13 (86.67) | 29.6817 |
| 2010's | 1 (6.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
Authors
| Authors | Studies |
|---|---|
| de Oliveira, CA; Guimarães, MR; Murad, LB; Paganelli, A; Vianna, LM | 1 |
| Andrews, H; Cheung, K; Corporan, T; Elkind, MS; Fink, DJ; Leifer, D; MacArthur, RB; Neils, G; Peerschke, E; Sacco, RL; Stillman, J | 1 |
| Andrews, H; Cheung, K; Corporan, T; Elkind, MS; Leifer, D; Liu, R; Macarthur, RB; Neils, G; Peerschke, E; Sacco, RL; Stillman, J | 1 |
| Bouzamondo, A; Corvol, JC; Hulot, JS; Lechat, P; Sanchez, P; Sirol, M | 1 |
| Clark, LT | 1 |
| Castilla-Guerra, L; Espino-Montoro, A; Fernandez Moreno, Mdel C; Jimérnez, MD; López-Chozas, JM | 1 |
| Dolga, AM; Eisel, UL; Luiten, PG; Nijholt, IM; Ostroveanu, A; Ten Bosch, Q | 1 |
| Delanty, N; Mohler, ER; Rader, DJ; Raps, EC | 1 |
| Rosenson, RS | 1 |
| Dotani, MI; Elnicki, DM; Gibson, CM; Jain, AC | 1 |
| Giroud, M; Lemesle-Martin, M; Manceau, E; Osseby, GV; Thomas, V | 1 |
| Durlach, V | 1 |
| Amin-Hanjani, S; Huang, PL; Liao, JK; Moskowitz, MA; Stagliano, NE; Yamada, M | 1 |
| Waters, DD | 1 |
| Basson, CT; Delanty, N; Vaughan, CJ | 1 |
Reviews
8 review(s) available for lovastatin and Stroke
| Article | Year |
|---|---|
Differential effects of lipid-lowering therapies on stroke prevention: a meta-analysis of randomized trials.
Topics: Anticholesteremic Agents; Atorvastatin; Cholestyramine Resin; Clofibrate; Colestipol; Gemfibrozil; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Lovastatin; Myocardial Infarction; Pravastatin; Pyrroles; Randomized Controlled Trials as Topic; Regression Analysis; Risk Assessment; Risk Factors; Simvastatin; Stroke; Treatment Failure; Treatment Outcome | 2003 |
Treating dyslipidemia with statins: the risk-benefit profile.
Topics: Atorvastatin; Cholesterol; Cholesterol, HDL; Coronary Disease; Drug Interactions; Fatty Acids, Monounsaturated; Fluvastatin; Heptanoic Acids; Humans; Hyperlipidemias; Indoles; Lovastatin; Pravastatin; Pyrroles; Randomized Controlled Trials as Topic; Risk Assessment; Simvastatin; Stroke; Triglycerides; United States | 2003 |
Statins and cerebrovascular disease: plaque attack to prevent brain attack.
Topics: Adult; Aged; Anticholesteremic Agents; Blood Vessels; Clinical Trials as Topic; Humans; Hypercholesterolemia; Lovastatin; Middle Aged; Pravastatin; Stroke | 1999 |
Biological basis for statin therapy in stroke prevention.
Topics: Animals; Humans; Lovastatin; Pravastatin; Simvastatin; Stroke | 2000 |
[Statins and stroke].
Topics: Anticholesteremic Agents; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Lipids; Lovastatin; Risk Factors; Stroke | 2001 |
[Statins: intervention studies, facts and perspectives].
Topics: Adult; Aged; Anticholesteremic Agents; Arteriosclerosis; Coronary Disease; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Lovastatin; Male; Middle Aged; Myocardial Infarction; Stroke | 2001 |
What do the statin trials tell us?
Topics: Anticholesteremic Agents; Clinical Trials as Topic; Coronary Disease; Female; Humans; Hypercholesterolemia; Lipoproteins, LDL; Lovastatin; Male; Outcome Assessment, Health Care; Pravastatin; Stroke; United States | 2001 |
Statin therapy and stroke prevention.
Topics: Anti-Inflammatory Agents; Anticholesteremic Agents; Atorvastatin; Brain Ischemia; Encephalitis; Endothelium, Vascular; Fibrinolytic Agents; Heptanoic Acids; Humans; Lovastatin; Nitric Oxide Synthase; Pyrroles; Stroke | 2001 |
Trials
2 trial(s) available for lovastatin and Stroke
| Article | Year |
|---|---|
The Neuroprotection with Statin Therapy for Acute Recovery Trial (NeuSTART): an adaptive design phase I dose-escalation study of high-dose lovastatin in acute ischemic stroke.
Topics: Acute Disease; Animals; Brain Ischemia; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Lovastatin; Research Design; Safety; Stroke; Time Factors | 2008 |
High-dose lovastatin for acute ischemic stroke: results of the phase I dose escalation neuroprotection with statin therapy for acute recovery trial (NeuSTART).
Topics: Acute Disease; Adult; Aged; Aged, 80 and over; Brain Ischemia; Dose-Response Relationship, Drug; Endpoint Determination; Ethnicity; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Liver Function Tests; Lovastatin; Male; Middle Aged; Neuroprotective Agents; Platelet Aggregation; Platelet Function Tests; Receptors, Tumor Necrosis Factor, Type I; Recovery of Function; Stroke; Young Adult | 2009 |
Other Studies
5 other study(ies) available for lovastatin and Stroke
| Article | Year |
|---|---|
Effects of alpha-tocopherol associated with lovastatin on brain tissue and memory function in SHRSPs.
Topics: alpha-Tocopherol; Animals; Antioxidants; Body Weight; Brain; Cell Count; Disease Models, Animal; Drinking; Eating; Exploratory Behavior; L-Lactate Dehydrogenase; Lovastatin; Male; Malondialdehyde; Maze Learning; Memory Disorders; Rats; Rats, Inbred SHR; Stroke | 2015 |
Statins and stroke: current clinical practice.
Topics: Age Factors; Atorvastatin; Cholesterol; Clinical Trials as Topic; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Lovastatin; Pravastatin; Pyrroles; Secondary Prevention; Simvastatin; Stroke | 2006 |
Lovastatin induces neuroprotection through tumor necrosis factor receptor 2 signaling pathways.
Topics: Aged; Alzheimer Disease; Animals; Anticholesteremic Agents; Disease Models, Animal; Glutamic Acid; Humans; Lovastatin; Mice; Mice, Inbred C57BL; Neurons; Neuroprotective Agents; NF-kappa B; Phosphorylation; Proto-Oncogene Proteins c-akt; Receptors, Tumor Necrosis Factor, Type II; Signal Transduction; Stroke; Tumor Necrosis Factor-alpha | 2008 |
Effect of preoperative statin therapy and cardiac outcomes after coronary artery bypass grafting.
Topics: Aged; Anticholesteremic Agents; Arrhythmias, Cardiac; Atorvastatin; Cause of Death; Coronary Artery Bypass; Coronary Disease; Female; Heart Failure; Heptanoic Acids; Humans; Hypercholesterolemia; Incidence; Lovastatin; Male; Middle Aged; Multivariate Analysis; Myocardial Infarction; Preoperative Care; Pyrroles; Recurrence; Retrospective Studies; Risk Factors; Simvastatin; Stroke; Treatment Outcome | 2000 |
Mevastatin, an HMG-CoA reductase inhibitor, reduces stroke damage and upregulates endothelial nitric oxide synthase in mice.
Topics: Animals; Aorta; Blood Flow Velocity; Blood Gas Analysis; Blood Pressure; Cerebrovascular Circulation; Cholesterol; Disease Models, Animal; Dose-Response Relationship, Drug; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Immunoblotting; Lovastatin; Male; Mice; Mice, Inbred Strains; Mice, Knockout; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Nitric Oxide Synthase Type III; RNA, Messenger; Stroke; Treatment Outcome; Up-Regulation | 2001 |